Soluble klotho and autosomal dominant polycystic kidney disease. - Wikidata - awgldk - TriplyDB

Soluble klotho and autosomal dominant polycystic kidney disease.

Soluble klotho and autosomal dominant polycystic kidney disease.

http://www.wikidata.org/entity/Q35758541

about

Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism Serum calcitriol levels in a patient with X-linked hypophosphatemia complicated by autosomal dominant polycystic kidney disease.Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.αKlotho and vascular calcification: an evolving paradigm.Infection and smoking are associated with decreased plasma concentration of the anti-aging protein, α-klotho Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody Fibroblast growth factor 23 and acute kidney injury.The emerging role of Klotho in clinical nephrology.Renal Production, Uptake, and Handling of Circulating αKlotho Urine proteomes of healthy aging humans reveal extracellular matrix (ECM) alterations and immune system dysfunction.Klotho as a potential biomarker and therapy for acute kidney injury.From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.The importance of klotho in phosphate metabolism and kidney disease.Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin.New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development.Laboratory aspects of circulating α-Klotho.Is Autosomal Dominant Polycystic Kidney Disease Becoming a Pediatric Disorder?New treatment paradigms for ADPKD: moving towards precision medicine.Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria.Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.Fibroblast growth factor 23 and soluble Klotho in patients with autosomal dominant polycystic kidney disease.

P2860

Q28542439-2B9A1FCE-3ADC-468D-9786-2C30A394CA9E Q30544587-21AAC6BA-1346-492B-9FDD-C776E85EC5CC Q33710251-2521124F-CDB8-4349-B688-29EB2C6E7186 Q33791650-907B3F96-BAC9-4B26-B6D3-24876B968907 Q33873450-4E7A7D46-199E-4090-A5F9-F57F7A6468DC Q34078872-6E478DA4-0257-4F2B-AF16-C7AAC77B669D Q34088174-D4016EE6-26F4-409F-8B02-AB8ECCA9F493 Q34204949-D7E76036-19B2-4357-A277-CBFFB51CC223 Q34487209-BF8BD71C-4BEF-4C57-978B-FA7631F6BBC5 Q35022247-0B134A60-2FD2-4159-8EF6-E6E67B4640A0 Q35690579-989E7547-F959-4ABA-B03C-FE225B7BBD01 Q36098355-4DA1EA1E-D624-45E1-9F04-E3DC137ED095 Q36417890-E115BF64-9B15-4476-8178-CF7727678158 Q37471129-3DDFB9E5-2271-4DA8-B395-863B0793015B Q38016065-037FBD26-5B3B-4CAB-86DE-620ACDC0C93C Q38076051-1DD5A898-8391-412A-AB75-B3995A851647 Q38205938-6EB6DB7F-644F-4A19-AB58-4953F2B63366 Q39001593-CC06DF5D-C739-4D2B-9CB5-349A9F135670 Q39030255-25B0C6EE-A60C-4098-ADAB-262F936F2612 Q46851255-84633582-D77F-405C-8E9A-B28104FA8744 Q47344872-C9B1AEEB-BF77-4159-A4C6-6AF1F2A603FE Q49494721-ECA8AC7F-778D-48F7-89E4-742612D9A07D Q51138838-108D5557-3198-402C-9FEE-14EB94A1BA10 Q51199021-C6A5E9DB-E85B-4AAF-BD87-741730330780 Q53776524-DD776559-1F52-40F8-9C1B-065E0730ACF7

P2860

Soluble klotho and autosomal dominant polycystic kidney disease.

http://www.wikidata.org/entity/Q35758541

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Soluble klotho and autosomal dominant polycystic kidney disease.

@ast

Soluble klotho and autosomal dominant polycystic kidney disease.

@en

type

label

Soluble klotho and autosomal dominant polycystic kidney disease.

@ast

Soluble klotho and autosomal dominant polycystic kidney disease.

@en

prefLabel

Soluble klotho and autosomal dominant polycystic kidney disease.

@ast

Soluble klotho and autosomal dominant polycystic kidney disease.

@en

P1433

Q35758541-45AC8C78-BC10-4448-9341-04A5A509A571

P1476

Q35758541-5C2EB9E6-9CC0-4006-A2DB-B8B1C5E029B0

P2093

Q35758541-0B0FA05E-F8B5-4410-8E75-8EDDBD7FAA16

Q35758541-0EDAC9ED-4006-40A2-9F8A-F0CE0A406CC6

Q35758541-300A9088-5EEC-41D9-AFC0-096372F9EE7A

Q35758541-5966CC93-6701-402D-B316-13CDCF375BCB

Q35758541-6B506244-2A6E-4B48-A2AE-0198651E3BD5

Q35758541-847DADD5-2FF3-4273-BE04-38A2C559A709

Q35758541-AE512CE2-5151-4F7A-9E18-84F24960814A

Q35758541-C3038366-547D-4342-B3BB-60A26A24FAE1

Q35758541-DA933B01-4659-4F92-B2A6-5FFBB85B2D98

Q35758541-FFA10999-280E-41AB-B704-CB91934BD5B5

P2860

Q35758541-003D85DA-35B2-44DA-B0F8-BD1EC01B7A79

Q35758541-09574321-EC82-4198-84D2-97E0D4A35E53

Q35758541-0D4E31F9-D1A0-48FE-9D27-EADDB61D2490

Q35758541-1B752351-ED32-4B20-B392-8995880ABC7B

Q35758541-2284A000-F788-49FF-BDA1-D72BDE8D0276

Q35758541-240B29DA-D1D2-4101-A2B2-63F9CD89E99D

Q35758541-298B2EEF-617F-406A-87A6-6835C629FF7E

Q35758541-2A22A112-F656-42E6-A88C-EE49CA373555

Q35758541-38032973-FAB1-427A-AF59-BAA772D7A957

Q35758541-3C454112-B37B-4EEC-A375-C7A84FD9AF8F

P304

Q35758541-21481223-D6B3-46C1-88A3-5AB0EAB63B35

P31

Q35758541-EBE1FBE2-D214-412B-BC41-98DBBD710500

P356

Q35758541-278AFD2B-D07E-48E7-B6B0-30178FECB15B

P433

Q35758541-3873BDC7-F523-4CBB-B7FC-35CE22E34246

P478

Q35758541-C5658153-FC64-4414-A7B0-1EDA039859B4

P50

Q35758541-27C38AED-CF54-412D-847A-80058C2EED97

Q35758541-80C0A0E8-A4E4-458D-8523-2BA880744473

Q35758541-B3A6A9A7-10E6-44C0-8896-2F9EC7AE9987

P577

Q35758541-B03642DA-0375-4380-B7EA-4BE70C5D6250

P698

Q35758541-C508A600-7D5E-42B1-B7C0-18DE406B8CDD

P921

Q35758541-2F3866FD-EC59-497B-9788-BDC4C782CB37

P932

Q35758541-62E118D8-B32D-4DD0-A91E-CE0A65923F95

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Soluble klotho and autosomal dominant polycystic kidney disease.

@en

P2093

Andreas D Kistler

http://www.w3.org/2001/XMLSchema#string

Andreas L Serra

http://www.w3.org/2001/XMLSchema#string

Carsten A Wagner

http://www.w3.org/2001/XMLSchema#string

Diane Poster

http://www.w3.org/2001/XMLSchema#string

Gustav Andreisek

http://www.w3.org/2001/XMLSchema#string

Ivana Pavik

http://www.w3.org/2001/XMLSchema#string

Katharina Rentsch

http://www.w3.org/2001/XMLSchema#string

Lena Ebner

http://www.w3.org/2001/XMLSchema#string

Philippe Jaeger

http://www.w3.org/2001/XMLSchema#string

Rudolf P Wüthrich

http://www.w3.org/2001/XMLSchema#string

P2860

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

Suppression of aging in mice by the hormone Klotho

A new equation to estimate glomerular filtration rate

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

Klotho converts canonical FGF receptor into a specific receptor for FGF23

alpha-Klotho as a regulator of calcium homeostasis

Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study.

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.09020911

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Schmid

Olivier Devuyst

Fabienne Krauer

P577

2011-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22193235

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

P932

3280025

http://www.w3.org/2001/XMLSchema#string